Search

Author/Creator Kotb, A

2. Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study. (14th April 2018)

Authors:
Novello, S; Mazières, J; Oh, I -J; de Castro, J; Migliorino, M R; Helland, Å; Dziadziuszko, R; Griesinger, F; Kotb, A; Zeaiter, A; Cardona, A; Balas, B; Johannsdottir, H K; Das-Gupta, A; Wolf, J
Journal:
Annals of oncology
Issue:
Volume 29:Number 6(2018)
Page Start:
1409
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. National prospective cohort study of the burden of acute small bowel obstruction. Issue 3 (22nd February 2019)

Authors:
Lee, M J; Sayers, A E; Drake, T M; Marriott, P J; Anderson, I D; Bach, S P; Bradburn, M; Hind, D; Verjee, A; Fearnhead, N S; Abercrombie, John; Acheson, Austin; Alderson, Derek; Anderson, Iain; Davies, Michael; Hamady, Zaed; Hollyman, Marianne; Hare, Sarah; Lee, Ellen; Northover, John
Journal:
BJS open
Issue:
Volume 3:Issue 3(2019)
Page Start:
354
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Outcomes of very high-power short-duration ablation using 90w for pulmonary vein isolation in patients with atrial fibrillation: a real world observation study. (3rd October 2022)

Authors:
Mavilakandy, A; Antoun, I; Kotb, A; Koev, I M; Barker, J; Vali, Z; Sidhu, B; Pooranachandran, V; Li, X; Ng, G A
Journal:
European heart journal
Issue:
Volume 43(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗